Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array

<p>Abstract</p> <p>Background</p> <p>Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide. Comprehensive genomic characterization of ESCC will further our understanding of the carcinogenesis process in this disease.</p> <p>Results</p...

Full description

Bibliographic Details
Main Authors: Goldstein Alisa M, Wang Quan-Hong, Su Hua, Lu Ning, Kong Li-Hui, Yang Howard H, Hu Ying, Wang Chaoyu, Hu Nan, Buetow Kenneth H, Emmert-Buck Michael R, Taylor Philip R, Lee Maxwell P
Format: Article
Language:English
Published: BMC 2006-11-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/7/299
Description
Summary:<p>Abstract</p> <p>Background</p> <p>Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide. Comprehensive genomic characterization of ESCC will further our understanding of the carcinogenesis process in this disease.</p> <p>Results</p> <p>Genome-wide detection of chromosomal changes was performed using the Affymetrix GeneChip 10 K single nucleotide polymorphism (SNP) array, including loss of heterozygosity (LOH) and copy number alterations (CNA), for 26 pairs of matched germ-line and micro-dissected tumor DNA samples. LOH regions were identified by two methods – using Affymetrix's genotype call software and using Affymetrix's copy number alteration tool (CNAT) software – and both approaches yielded similar results. Non-random LOH regions were found on 10 chromosomal arms (in decreasing order of frequency: 17p, 9p, 9q, 13q, 17q, 4q, 4p, 3p, 15q, and 5q), including 20 novel LOH regions (10 kb to 4.26 Mb). Fifteen CNA-loss regions (200 kb to 4.3 Mb) and 36 CNA-gain regions (200 kb to 9.3 Mb) were also identified.</p> <p>Conclusion</p> <p>These studies demonstrate that the Affymetrix 10 K SNP chip is a valid platform to integrate analyses of LOH and CNA. The comprehensive knowledge gained from this analysis will enable improved strategies to prevent, diagnose, and treat ESCC.</p>
ISSN:1471-2164